<?xml version="1.0" encoding="UTF-8"?><!-- All of the content featured or displayed on the Website, including without limitation text, graphics, photographs, images, moving images, sound, and illustrations ("Content"), is owned by AAN its licensors and/or its Content providers. All elements of the Website, including without limitation the general design and the Content, are protected by trade dress, copyright, moral rights, trademark and other laws relating to intellectual property rights. The Services and the Website may only be used for the intended purpose for which such Website and Services are being made available. Except as may be otherwise indicated in specific documents within the Website, you are authorized to view, play, print and download documents, audio and video found on our Website for personal, informational, and non-commercial purposes only. You may not modify any of the materials and you may not copy, distribute, transmit, display, perform, reproduce, publish, license, create derivative works from, transfer or sell any information or work contained on the Website. Except as authorized under the copyright laws, you are responsible for obtaining permission before reusing any copyrighted material that is available on the Website. --><?xml-stylesheet type="text/xsl" href="rss.xsl"?>
<!DOCTYPE rss  [
	<!ENTITY nbsp   "&#160;">
	<!ENTITY copy   "&#169;">
	<!ENTITY reg    "&#174;">
	<!ENTITY trade  "&#8482;">
	<!ENTITY mdash  "&#8212;">
	<!ENTITY ldquo  "&#8220;">
	<!ENTITY rdquo  "&#8221;"> 
	<!ENTITY pound  "&#163;">
	<!ENTITY yen    "&#165;">
	<!ENTITY euro   "&#8364;">
	<!ENTITY quote	"&quot;">
]>
<rss version="2.0" xmlns:aan="http://www.aan.com/rss/rss.dtd">
<channel>
	<title>Autism and Child Neurology</title>
	<description>Subscribe to the latest research about Autism and Child Neurology as soon as it is published in &lt;em&gt;Neurology&lt;/em&gt;&lt;sup&gt;&amp;reg;&lt;/sup&gt;, the medical journal of the American Academy of Neurology.  &lt;em&gt;Neurology&lt;/em&gt; is the world&apos;s most widely read and highly cited peer-reviewed neurology journal.</description>
	<link>http://www.aan.com/rss/?event=feed&amp;channel=17</link>
	<language>en</language>
	<managingEditor>ababb@aan.com</managingEditor>
	<webMaster>kwiersma@aan.com</webMaster>
	<pubDate>Thu, 13 Nov 2008 16:32:09 GMT</pubDate>
	<lastBuildDate>Sat, 21 Nov 2009 19:26:51 GMT</lastBuildDate>
	<generator>AXON RSS Extension</generator>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<aan:feedback>
		<aan:email>ababb@aan.com</aan:email>
		<aan:label>Channel Feedback</aan:label>
	</aan:feedback>
	<image>
		<title>http://www.aan.com</title>
		<link>http://www.aan.com/rss/?event=feed&amp;channel=17</link>
		<url>http://www.aan.com/rss/images/channels/channel_17_s.jpg</url>
		<width>144</width>
		<height>144</height>
		<description>Subscribe to the latest research about Autism and Child Neurology as soon as it is published in &lt;em&gt;Neurology&lt;/em&gt;&lt;sup&gt;&amp;reg;&lt;/sup&gt;, the medical journal of the American Academy of Neurology.  &lt;em&gt;Neurology&lt;/em&gt; is the world&apos;s most widely read and highly cited peer-reviewed neurology journal.</description>
	</image>
	<aan:isitunes>false</aan:isitunes>
	<item>
		<aan:cme>1</aan:cme>
		<title>AAN Launches New Book Series to Help Patients and Caregivers</title>
		<link>http://www.aan.com/rss/index.cfm/getfile/AAN_94.pdf</link>
		<description>Media Contacts:
Angela Babb, ababb@aan.com, (651) 695-2789
Rachel Seroka, rseroka@aan.com, (651) 695-2738
 
AAN Launches New Book Series to Help Patients and Caregivers

ST. PAUL, Minn. - Following up on the success of Neurology Now&amp;reg;, the free and award-winning patient and caregiver magazine of the American Academy of Neurology, the Academy has announced plans to launch a new series of books for neurology patients and caregivers in 2009 to be called Neurology Now Books&amp;trade;.   The Academy has expanded its publishing division, AAN Press, to publish this new book series.

Titles planned to publish in the Neurology Now Books&amp;trade; series include coping with multiple sclerosis, brain tumors, and taste and smell disorders in the first year.  A fourth publication is also planned for late next year.

&quot;With one in six people now affected by a neurologic disorder, there&apos;s tremendous demand for the latest information on how to best meet the needs of this fast-growing population of patients and caregivers.  Neurology Now Books&amp;trade; will fulfill this growing demand,&quot; said Lisa M. Shulman, MD, Editor of Neurology Now Books&amp;trade;, and a neurologist with the University of Maryland School of Medicine and Fellow of the American Academy of Neurology. 

&quot;With the experience the Academy has had in publishing Neurology Now&amp;reg; magazine, it&apos;s sought to advance patient care and has developed an appreciation for the needs and concerns of neurology patients and caregivers.  Neurology Now Books&amp;trade; will continue to further our mission of improving patient care and public understanding of disorders of the brain and nervous system,&quot; said Shulman.

Each issue of Neurology Now&amp;reg; magazine reaches nearly one million readers. It is the only consumer magazine in the country devoted to the management of the range of neurologic disorders.  The magazine offers information on treatment and cutting-edge research for such neurologic disorders as Alzheimer&apos;s disease, epilepsy, migraine, Parkinson&apos;s disease and more. For information on receiving a free subscription to Neurology Now&amp;reg; magazine, visit www.neurologynow.com.

AAN Press through Demos Medical Publishing published an earlier series of books for neurology patients and caregivers that will continue to be available for purchase via the AAN Store&amp;trade;.

Other AAN Press publications are Neurology&amp;reg;, the most widely read and highly cited peer-reviewed neurology journal, Neurology Now&amp;reg; magazine, and Neurology Today&amp;reg;.

The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer&apos;s disease, epilepsy, Parkinson&apos;s disease, and multiple sclerosis. 

For more information about the American Academy of Neurology, visit www.aan.com.</description>
		<guid>http://www.aan.com/rss/index.cfm/getfile/AAN_94.pdf</guid>
		<author>ababb@aan.com</author>
		<enclosure url="http://www.aan.com/rss/index.cfm/getfile/AAN_94.pdf" length="2597" type="application/pdf" />
		<pubDate>Tue, 23 Sep 2008 15:04:51 GMT</pubDate>
	</item>
	<item>
		<aan:cme>1</aan:cme>
		<title>Is ADHD More Likely to Affect Movement in Boys or Girls?</title>
		<link>http://www.aan.com/rss/index.cfm/getfile/AAN_121.pdf</link>
		<description>ST. PAUL, Minn. - Attention deficit hyperactivity disorder (ADHD) appears to affect movement in boys more than it does in girls, according to a study published in the November 4, 2008, issue of Neurology&amp;reg;, the medical journal of the American Academy of Neurology. ADHD is one of the most common mental disorders found in children. Symptoms include impulsiveness, hyperactivity, such as not being able to sit still, and inattention or constant daydreaming. Few studies have been done that compare ADHD and movement in both boys and girls.

Researchers tested the movement abilities of 132 boys and girls with ADHD and 136 without the disorder.  The children were between the ages of seven and 15 years and were tested for how fast and how well they could tap their toes, walk on their heels, maintain balance and keep a steady rhythm during a task compared to scores typical for their age.

The study found that girls with ADHD and the control group of children without ADHD were twice as likely to be able to control their movements for their age compared to boys with ADHD, who showed continued difficulties.

&quot;Our findings suggest that the differences between boys and girls with ADHD show up not only in behavior and symptoms but also in development of movement control, likely because girls&apos; brains mature earlier than boys&apos; brains,&quot; said study author E. Mark Mahone, PhD, with the Kennedy Krieger Institute and Johns Hopkins University School of Medicine in Baltimore, MD. 

&quot;More studies related to ADHD and movement are needed that look at boys and girls separately and at younger ages,&quot; said Mahone.

The study was supported by the National Institute of Neurological Disorders and Stroke, Kennedy Krieger Institute&apos;s Developmental Disabilities Research Center and the Johns Hopkins University School of Medicine Institute for Clinical and Translational Research.

The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as stroke, Alzheimer&apos;s disease, epilepsy, Parkinson&apos;s disease, and multiple sclerosis.

For more information about the American Academy of Neurology, visit www.aan.com.</description>
		<guid>http://www.aan.com/rss/index.cfm/getfile/AAN_121.pdf</guid>
		<author>ababb@aan.com</author>
		<enclosure url="http://www.aan.com/rss/index.cfm/getfile/AAN_121.pdf" length="2382" type="application/pdf" />
		<pubDate>Mon, 03 Nov 2008 22:00:00 GMT</pubDate>
	</item>
	<item>
		<aan:cme>1</aan:cme>
		<title>Epilepsy Drug May Increase Risk of Autism in Children</title>
		<link>http://www.aan.com/rss/index.cfm/getfile/AAN_1824.pdf</link>
		<description>A new study shows that women who take the epilepsy drug valproate while pregnant may significantly increase their child&apos;s risk of developing autism. The preliminary research is published in the December 2, 2008, print issue of Neurology&amp;reg;, the medical journal of the American Academy of Neurology. 

The ongoing study involves 632 children, nearly half of whom were exposed to epilepsy drugs during gestation.  Of the children whose mothers took epilepsy drugs while pregnant, 64 were exposed to valproate, 44 to lamotrigine, 76 to carbamazepine and 65 to other epilepsy drugs.  Of the 632 children in the study, nine have been diagnosed with autism and one has shown symptoms of the disorder. The children were tested at one, three and six years old. Two-thirds of the children were six years old by the end of the study.

The study found seven of the children with autism had mothers who took an epilepsy drug while pregnant, four of those children were exposed to valproate while a fifth child&apos;s mother took a combination of valproate and lamotrigine.  The children whose mothers were given valproate during pregnancy were seven times more likely to develop autism compared to children whose mothers did not take an epilepsy drug while pregnant. This risk was not seen with the other epilepsy drugs. None of the children in the study had any known family history of autism.

&quot;The potential risk for autism in this study was substantial for children whose mothers took valproate while pregnant, but more research needs to be done since these are early findings,&quot; says study author Gus Baker, PhD, FBPsS, of the University of Liverpool in the United Kingdom.&quot;However, women who take valproate while pregnant should be informed of the possible risks of autism and are encouraged to discuss them with their doctor. Those who are taking valproate should not stop their treatment without speaking to their doctor first.&quot; 

Other studies have shown that valproate is more likely to cause birth defects than other epilepsy drugs. 

Symptoms of autism include difficulty in language development, a lack of attention, social problems and the inability to understand other people&apos;s feelings.  

The study was conducted by the Liverpool and Manchester Neurodevelopment Group, a multidisciplinary group consisting of psychologists, geneticists, neurologists, midwives and support staff.



The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as multiple sclerosis, restless legs syndrome, Alzheimer&apos;s disease, narcolepsy, and stroke.

For more information about the American Academy of Neurology, visit http://www.aan.com/go/pressroom.
</description>
		<guid>http://www.aan.com/rss/index.cfm/getfile/AAN_1824.pdf</guid>
		<author>ababb@aan.com</author>
		<enclosure url="http://www.aan.com/rss/index.cfm/getfile/AAN_1824.pdf" length="2624" type="application/pdf" />
		<pubDate>Mon, 01 Dec 2008 22:00:00 GMT</pubDate>
	</item>
	<item>
		<aan:cme>1</aan:cme>
		<title>Screening to Help Prevent Stroke in Kids Increases, But Limited Access a Problem</title>
		<link>http://www.aan.com/rss/index.cfm/getfile/AAN_1881.pdf</link>
		<description>The number of children with a certain blood disorder undergoing an ultrasound to help prevent stroke is up significantly in the past 10 years since the publication of a major study showing its benefits. However, limited access to labs that perform this type of screening appears to be a barrier to helping these children who are at a high risk of stroke.  The research is published in the April 14, 2009, print issue of Neurology&amp;reg;, the medical journal of the American Academy of Neurology.  

Researchers followed 157 children with sickle cell disease in northern California for an average of 8.5 years. Sickle cell disease is a lifelong blood disorder that increases a child&apos;s risk of stroke.  Roughly one out of 10 children with the disease suffers a stroke by age 20.

For the study, researchers determined how many children underwent a transcranial Doppler ultrasound (TCD) screening since 1998, when a major study, known as the STOP trial, was published.  The STOP trial showed a more than 90-percent reduction in the stroke rate of children with sickle cell disease who received a TCD screening and were identified as having a high risk of stroke and could therefore have blood transfusion therapy.

Since the STOP trial, the current study found the rate of TCD screening among children with sickle cell disease has increased six-fold while the annual stroke rate has dropped by more than half.  However, researchers found children living farther away from a vascular laboratory were less likely to be screened.

&quot;Stroke in children with sickle cell disease should be a largely preventable disease, however, not all children at risk are getting screened,&quot; said Heather J. Fullerton, MD, MAS, with the University of California, San Francisco. &quot;Limited access to labs that perform TCD screening, even among kids with comprehensive health insurance, appears to be a barrier to helping these kids reduce their high risk of stroke. Increased availability of these screening labs may help prevent stroke in these high risk children.&quot;

Guidelines from the American Academy of Neurology recommend TCD screening of children with sickle cell disease beginning at age two.

The study was supported by a grant from the Thrasher Research Fund.


The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as multiple sclerosis, restless legs syndrome, Alzheimer&apos;s disease, narcolepsy, and stroke. 

For more information about the American Academy of Neurology, visit www.aan.com.
</description>
		<guid>http://www.aan.com/rss/index.cfm/getfile/AAN_1881.pdf</guid>
		<author>ababb@aan.com</author>
		<enclosure url="http://www.aan.com/rss/index.cfm/getfile/AAN_1881.pdf" length="2501" type="application/pdf" />
		<pubDate>Mon, 13 Apr 2009 21:00:00 GMT</pubDate>
	</item>
	<item>
		<aan:cme>1</aan:cme>
		<title>Can Children Outgrow Chronic Daily Headache?</title>
		<link>http://www.aan.com/rss/index.cfm/getfile/AAN_1931.pdf</link>
		<description>Most children who suffer from chronic daily headache may outgrow the disabling condition, according to research published in the July 15, 2009, online issue of Neurology&amp;reg;, the medical journal of the American Academy of Neurology. Nearly 1.5 percent of middle school children are affected by chronic daily headache, which includes chronic migraines and tension-type headaches. 

&quot;Our results suggest there is hope for children who experience these headaches and for their parents, who also deal with the frustration and considerable disability that this condition can bring,&quot; said study author Shuu-Jiun Wang, MD, of the Taipei Veterans General Hospital and National Yang-Ming University School of Medicine in Taipei, Taiwan. &quot;Over time, most of these children get better, eventually having less frequent migraine headaches as young adults.&quot;

For the study, scientists followed 122 children in middle school with chronic daily headache between the ages of 12 and 14 years old. Chronic daily headache was defined as experiencing 15 or more headache days per month, with each headache lasting for two or more hours per day.  

The study found 60 percent of the children no longer had chronic daily headache after one year and 75 percent no longer had the symptoms after two years.  After eight years, only 12 percent of the 103 children tested still experienced symptoms of chronic daily headache. However, 75 percent of the children had episodic migraine or probable migraine, while 11 percent became headache free after eight years.

&quot;Parents and children should be prepared for the possibility that while chronic daily headache may get better over time, headaches in general may never fully go away, but for most children the headaches are much less frequent when they become young adults,&quot; said Wang.

The study found migraine history was a major risk factor for children having chronic daily headache into young adulthood.  Children who had chronic daily headache before age 13, those who overused pain medications, and those with the condition for more than two years were more likely to have higher headache frequency and the condition eight years later.

The study was supported by the Taipei Veterans General Hospital and Kaohsiung Medical University Chung-Ho Memorial Hospital.



The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Parkinson&apos;s disease, ALS (Lou Gehrig&apos;s disease), dementia, West Nile virus, and ataxia. For more information about the American Academy of Neurology, visit www.aan.com or www.TheBrainMatters.org.
</description>
		<guid>http://www.aan.com/rss/index.cfm/getfile/AAN_1931.pdf</guid>
		<author>ababb@aan.com</author>
		<enclosure url="http://www.aan.com/rss/index.cfm/getfile/AAN_1931.pdf" length="2558" type="application/pdf" />
		<pubDate>Wed, 15 Jul 2009 21:00:00 GMT</pubDate>
	</item>
	<item>
		<aan:cme>1</aan:cme>
		<title>Guideline: Kids with Small Head Size at Risk of Neurologic Problems, Screening Needed</title>
		<link>http://www.aan.com/rss/index.cfm/getfile/AAN_1952.pdf</link>
		<description>A new guideline from the American Academy of Neurology, developed in full collaboration with the Child Neurology Society, finds that children with microcephaly-that is, children whose head size is smaller than that of 97 percent of children-are at risk of neurologic and cognitive problems and should be screened for these problems. The guideline is published in the September 15, 2009, issue of Neurology&amp;reg;, the medical journal of the American Academy of Neurology.

Microcephaly is common, affecting more than 25,000 infants in the United States each year.  If it is not present at birth, it usually has developed by the time a child is two years old.  While microcephaly is not a disease, it is an important sign that may point to other conditions.

&quot;The evidence suggests that children with microcephaly are more likely to have certain neurologic conditions, such as epilepsy and cerebral palsy, as well as mental retardation and eye and ear disorders,&quot; said lead guideline author Stephen Ashwal, MD, a child neurologist at Loma Linda University School of Medicine in Loma Linda, California, and a Fellow of the American Academy of Neurology.  &quot;In fact, the evidence shows that children with microcephaly are at risk for developmental delay and learning disorders. For these reasons, it is necessary for doctors to recognize microcephaly and check the child for these associated problems, which often require special treatments. This is an important recommendation, as it allows doctors to provide more accurate advice and counseling to families who have a child with microcephaly.&quot;

Doctors may also consider screening for coexisting conditions, such as epilepsy and cerebral palsy. &quot;Forty percent of children with microcephaly also have epilepsy, 20 percent also have cerebral palsy, 50 percent also have mental retardation, and 20 to 50 percent also have eye and ear problems,&quot; said Ashwal.

Brain scans such as an MRI or CT scan as well as genetic testing may be useful in identifying the causes of microcephaly. Ashwal says even if a small head size runs in families, it is still important to see a doctor due to the risk of other conditions. He points out that it is also important to tell the doctor about any family history of neurologic disease. &quot;It should be noted though, that some children with small head size have normal development and do not develop any related conditions or problems,&quot; Ashwal said.  

The American Academy of Neurology has posted a video demonstrating how a doctor measures a child&apos;s head circumference for microcephaly. To view the video, visit the AAN&apos;s YouTube channel at www.youtube.com/AANChannel.

The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care through education and research. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as epilepsy, dystonia, migraine, Huntington&apos;s disease and dementia. 
 
For more information about the American Academy of Neurology, visit www.aan.com or www.thebrainmatters.org.</description>
		<guid>http://www.aan.com/rss/index.cfm/getfile/AAN_1952.pdf</guid>
		<author>ababb@aan.com</author>
		<enclosure url="http://www.aan.com/rss/index.cfm/getfile/AAN_1952.pdf" length="2694" type="application/pdf" />
		<pubDate>Mon, 14 Sep 2009 21:00:00 GMT</pubDate>
	</item>
	<item>
		<aan:cme>1</aan:cme>
		<title>Children with Autism More Likely to Have Handwriting Problems</title>
		<link>http://www.aan.com/rss/index.cfm/getfile/AAN_1974.pdf</link>
		<description>EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, MONDAY, NOVEMBER 9, 2009
Media Contacts:
Rachel Seroka, rseroka@aan.com, (651) 695-2738
Angela Babb, ababb@aan.com, (651) 695-2789



Children with Autism More Likely to Have Handwriting Problems

ST. PAUL, Minn. -Children with autism may have lower quality handwriting and trouble forming letters compared to children without autism, according to a study published in the November 10, 2009, print issue of &lt;a href=&quot;http://www.neurology.org&quot;&gt;Neurology&amp;reg;&lt;/a&gt;, the medical journal of the American Academy of Neurology. 

The study included 28 children between the ages of eight and 13. Half of the children had autism spectrum disorder. The other half had no developmental, psychiatric or brain disorders. All of the children scored within the normal range for perceptual reasoning on an IQ test.

The children were given the Minnesota Handwriting Assessment Test, which uses a scrambled sentence to eliminate any speed advantage for more fluent readers. The sentence used on the test was &quot;the brown jumped lazy fox quick dogs over.&quot; Participants were asked to copy the words in the sentence, making the letters the same size and shape as the sample using their best handwriting. The handwriting was scored based on five categories: legibility, form, alignment, size and spacing. The children&apos;s motor skills, including balance and timed movements, were also examined and given a rating.

The research found that half of the children with autism earned less than 80 percent of the total possible points on the handwriting assessment, compared to only one child in the group without autism. In addition, nine of the 14 children with autism scored below 80 percent on the form category of the handwriting assessment, compared to only two of the 14 children without autism.

&quot;Our results suggest that therapies targeting motor skills may help improve handwriting in children with autism, which is important for success in school and building self-esteem,&quot; said study author Amy Bastian, PhD, of the Kennedy Krieger Institute and Johns Hopkins School of Medicine in Baltimore, MD. &quot;Such therapies could include training of letter formation and general training of fine motor control to help improve the quality of their writing.&quot;

While overall quality of handwriting was worse in children with autism spectrum disorders, they were still able to align, space and size their letters just as well as children without autism.

The study was supported by an Autism Speaks Pre-Doctoral Fellowship and by the National Institutes of Health.

The American Academy of Neurology, an association of more than 21,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as multiple sclerosis, restless legs syndrome, Alzheimer&apos;s disease, narcolepsy, and stroke.

For more information about the American Academy of Neurology, visit &lt;a href=&quot;http://www.aan.com&quot;&gt;AAN.com&lt;/a&gt;or &lt;a href=&quot;http://www.thebrainmatters.org&quot;&gt;TheBrainMatters.org&lt;/a&gt;.

VIDEO: http://www.youtube.com/AANChannel 
TEXT: http://www.aan.com/press 
TWEETS: http://www.twitter.com/AANPublic</description>
		<guid>http://www.aan.com/rss/index.cfm/getfile/AAN_1974.pdf</guid>
		<author>ababb@aan.com</author>
		<enclosure url="http://www.aan.com/rss/index.cfm/getfile/AAN_1974.pdf" length="3421" type="application/pdf" />
		<pubDate>Mon, 09 Nov 2009 22:00:00 GMT</pubDate>
	</item>
</channel>
</rss>

